Digestive and Liver Disease

Aims & Scope

Digestive and Liver Disease is an international journal of Gastroenterology and Hepatology.

It is the official journal of Italian Association for the Study of the Liver (AISF); Italian Association for the Study of the Pancreas (AISP); Italian Association for Digestive Endoscopy (SIED); Italian Association for Hospital Gastroenterologists and Digestive Endoscopists (AIGO); Italian Society of Gastroenterology (SIGE); Italian Society of Pediatric Gastroenterology and Hepatology (SIGENP) and Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD).

Digestive and Liver Disease publishes papers on basic and clinical research in the field of gastroenterology and hepatology.

Contributions consist of: Original Papers Correspondence to the Editor Editorials, Reviews and Special Articles Progress Reports Image of the Month Congress Proceedings Symposia and Mini-symposia.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.8
2024	4.00

SJR (SCImago Journal Rank)

Year	Value
2024	1.091

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	113

Journal Rank

Year	Value
2024	4184

Journal Citation Indicator

Year	Value
2024	2260

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease

  Citation: 1212

  Authors: Jeong-Hoon, Donghee, Hwa Jung, Chang-Hoon, Jong In, Won, Yoon Jun, Jung-Hwan, Sang-Heon, Myung-Whun, Hyo-Suk

• Actinobacteria: A relevant minority for the maintenance of gut homeostasis

  Citation: 638

  Authors: Cecilia, Loris Riccardo, Gianenrico, Giulia, Vincenzo, Antonio

• Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

  Citation: 550

  Authors: Amedeo, Stefano, Giulio, Paul, Paola

• European experts consensus statement on cystic tumours of the pancreas

  Citation: 396

  Authors: Marco, Caroline, Roberto, Gunter, Jens, Colin, Helmut, Riccardo, Eric, Matthias, Ralf, L, M, N, Ã…, U, M, D, C, G, M, G, I, M, H, P, IP, S, T, JR, G, M, L, J, M, R, J, C, K, A, E, T, R, R, R, T, E, SW, C, J, G

• The changing pattern of epidemiology in hepatocellular carcinoma

  Citation: 394

  Authors: Helena, Donna L., Hashem B.

• From the metabolic syndrome to NAFLD or vice versa?

  Citation: 376

  Authors: Ester, Elisabetta, Anna, Samuele, Hannele, Gianluca

• The bile acid TGR5 membrane receptor: From basic research to clinical application

  Citation: 373

  Authors: Henri, Yvette, Alan F.

• Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

  Citation: 366

  Authors: Amedeo, Stefano, Curtis K., Stefano, Christopher D., Stephen H., Helena, Antonio, Mariana V., Luca, Giovanni

• Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study

  Citation: 349

  Authors: M., F., L., M., P., F., S., G., P., G., G., R., M., A.

• Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD)

  Citation: 334

  Authors: M., M., H., K., H., H., Y., K., T., H., N., H., Y., M., K., S., M., H., S., N., S., A.

---